RE:The breadcrumbs I see in the IRSome good deductive reasoning there.
Re: another pot.
Doesn't necessarily need to be another pot for Dialco useability Trial, if a new (another? same one?) strategic partner takes the reigns/kicks in, in exchange for a piece. Lots of ways expenses can be shared, and or equity given.
With over subscription, I suspect that the bridge is bigger than you fmight first think. Closer to $ 10M ? Then there is tranche # 2 from Baxter (at 90 patients) and if all goes well with SP, warrant exercising. Agree that the latter two require some faith (faster enrollment, and a higher SP). but there is another possible $10M there as well.
Re: strategic Options and Infomed...surely Infomed would need to sign of on any assignment of Rights.
MM